Jeon Byeong Tak, Naveed Muhammad, Puleo Matthew, Kim Woo-Yang, Kim Min-Ho
Department of Biological Sciences, Kent State University, Kent, OH, 44242, USA.
Sci Rep. 2025 Jul 8;15(1):24425. doi: 10.1038/s41598-025-10441-z.
The principle of magnetic hyperthermia is to generate localized heating on target proteins, cells and tissue that are targeted by magnetic nanoparticles (MNPs) upon stimulation by remotely applied high frequency alternating magnetic field (AMF). Beyond its traditional applications in hyperthermia therapy, recent studies demonstrated the feasibility of magnetic hyperthermia as a new strategy for neural stimulation. The objective of this study is to examine the feasibility of localized magnetic hyperthermia (i.e. MNP/AMF hyperthermia) as a new strategy for brain stimulation, especially in modulating microglia activity and behaviors in vivo. This was examined by correlating a varying degree of MNP/AMF-induced thermal dose with the extent of microglial activation in the mouse brain. The MNP/AMF hyperthermia stimulation applied at a mild thermal dose to the mouse hippocampus significantly increased the infiltration of microglia and altered their morphology towards reactive and ameboid-like phenotypes in a thermal dose-dependent manner. Importantly, these responses were associated with increased expression of heat shock protein 70 (HSP70), a molecular chaperon protein, and LC3II, a marker of autophagic activity. Our findings support the feasibility of developing mild magnetic hyperthermia as a new strategy for localized stimulation of brain tissue.
磁热疗的原理是,在远程施加的高频交变磁场(AMF)刺激下,磁性纳米颗粒(MNP)靶向的目标蛋白质、细胞和组织会产生局部加热。除了在热疗中的传统应用外,最近的研究表明磁热疗作为一种神经刺激新策略具有可行性。本研究的目的是检验局部磁热疗(即MNP/AMF热疗)作为一种脑刺激新策略的可行性,特别是在体内调节小胶质细胞活性和行为方面。通过将不同程度的MNP/AMF诱导热剂量与小鼠脑中的小胶质细胞激活程度相关联来进行检验。以温和热剂量对小鼠海马体施加MNP/AMF热疗刺激,显著增加了小胶质细胞的浸润,并以热剂量依赖性方式使其形态转变为反应性和阿米巴样表型。重要的是,这些反应与热休克蛋白70(HSP70,一种分子伴侣蛋白)和LC3II(自噬活性标志物)的表达增加有关。我们的研究结果支持了将温和磁热疗开发为一种局部刺激脑组织新策略的可行性。
Arch Ital Urol Androl. 2025-6-30
Cochrane Database Syst Rev. 2024-5-29
Electromagn Biol Med. 2025-6-29
Cochrane Database Syst Rev. 2018-2-12
Psychopharmacol Bull. 2024-7-8
Cochrane Database Syst Rev. 2024-8-2
Front Bioeng Biotechnol. 2024-8-5
Signal Transduct Target Ther. 2023-9-22
Mol Neurodegener. 2023-4-21
Ageing Res Rev. 2023-3
Front Immunol. 2022
Cancers (Basel). 2022-6-23